Last updated: February 14, 2023
Sponsor: First Affiliated Hospital of Zhejiang University
Overall Status: Active - Enrolling
Phase
N/A
Condition
Vascular Diseases
Stress
Williams Syndrome
Treatment
N/AClinical Study ID
NCT04421118
HEPIC2002
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Criteria: Inclusion Criteria:
- age 18-75 years;
- high-risk treatment failure (e.g.Child-Pugh C or B grade with variceal bleeding);
- conventional drugs and endoscopic treatment of esophageal variceal bleeding are notgood;
- End-stage liver disease with variceal bleeding before liver transplantation;
- successful implementation of TIPS;
- good compliance with the requirements formulated by the study;
- with written informed consent.
Exclusion
Exclusion Criteria:
- Liver transplantation in the past or planning liver transplantation in the 6 months;
- Common TIPS contraindications (e.g.NYHA level 2 of congestive heart failure ,historyof pulmonary hypertension, portal vein trunk thrombosis, multiple liver cysts,orintrahepatic bile duct dilatation);
- severe liver dysfunction: prothrombin activity <40% or bilirubin> 50μmol / L orChild-Pugh score> 12;
- history of hepatic encephalopathy;
- serum creatinine> 133μmol / L;
- severe hyponatremia (blood sodium <125mmol / L);
- uncontrollable infections;
- allergic to intravenous contrast agent;
- subject refused to participate in the trial or without the ability to participate ininformed consent;
- previous history of TIPS treatment;
- any comorbidities or conditions that affect the test results as judged by theinvestigator.
Study Design
Total Participants: 60
Study Start date:
June 11, 2021
Estimated Completion Date:
December 20, 2024
Study Description
Connect with a study center
First Affiliated Hospital of Zhejiang University
Hangzhou,
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.